Although multivariate analysis did not identify PLK4 as an independent prognostic factor, RNA expression data from the Human Protein Atlas confirmed that high PLK4 levels were associated with shorter overall survival in melanoma patients [12]. This evidence concerns the gene PLK4 and melanoma.